Beref Pharmaceuticals Private Limited
Produces and sells a variety of pharmaceutical products since 2021.
2021 | Tiruvallur, Tamil Nadu (India) | Active
Beref Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 2.89 Cr
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.35 Cr
About Beref Pharmaceuticals
Beref Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 January 2021 (Four years and one month 23 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.89 Cr.
The company currently has active open charges totaling ₹2.35 Cr.
Karuppiah Murugupandian, Raju Ramamoorthy, and Vinayagam Senthil serve as directors at the Company.
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299TN2021PTC140503
- Company No.
140503
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
Who are the key members and board of directors at Beref Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karuppiah Murugupandian  | Managing Director | 02-Jan-2021 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raju Ramamoorthy | Director | 02-Jan-2021 | Current |
| Vinayagam Senthil | Director | 08-Dec-2022 | Current |
Financial Performance of Beref Pharmaceuticals.
Enhance accessibility to Beref Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Beref Pharmaceuticals?
Unlock access to Beref Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹2.35 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 2.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Apr 2023 | Others | ₹6.00 M | Open |
| 19 Aug 2021 | Others | ₹1.75 Cr | Open |
How Many Employees Work at Beref Pharmaceuticals?
Beref Pharmaceuticals has a workforce of 19 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Beref Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beref Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.